Although the participation of key canonical pathways, such as those involving PI3K-Akt, MAPK, IGF, FGF, MET and mTOR [2], is well established in different cancers, these pathways cannot capture the complex and context-dependent cellular rewiring patterns behind distinct cancer phenotypes. This evidence concerns the gene IGF1 and cancer.